| 1. Descriptive Epidemiology and Survival Analysis of Prolactinomas and Cushing’s Disease in Korea |
Page:688—696 |
| 2. Identification of Protein Z as a Potential Novel Biomarker for the Diagnosis of Prediabetes |
Page:572—573 |
| 3. Receptor-Mediated Muscle Homeostasis as a Target for Sarcopenia Therapeutics |
Page:478—490 |
| 4. Expression of LONP1 Is High in Visceral Adipose Tissue in Obesity, and Is Associated with Glucose and Lipid Metabolism |
Page:661—671 |
| 5. Long-Term Treatment of Postmenopausal Osteoporosis |
Page:544—552 |
| 6. Current Guidelines for Management of Medullary Thyroid Carcinoma |
Page:514—524 |
| 7. Evaluation of Iodine Status among Korean Patients with Papillary Thyroid Cancer Using Dietary and Urinary Iodine |
Page:607—618 |
| 8. Efficacy and Safety of the New Appetite Suppressant, Liraglutide: A Meta-Analysis of Randomized Controlled Trials |
Page:647—660 |
| 9. Cushing Syndrome Associated Myopathy: It Is Time for a Change |
Page:564—571 |
| 10. Subclinical Hypothyroidism: Prevalence, Health Impact, and Treatment Landscape |
Page:500—513 |
| 11. Recent Advances in Understanding Peripheral Taste Decoding I: 2010 to 2020 |
Page:469—477 |
| 12. Antithyroid Drug Treatment in Graves’ Disease |
Page:491—499 |
| 13. Heart Rate Variability in Postoperative Patients with Nonfunctioning Pituitary Adenoma |
Page:678—687 |
| 14. Clinicopathological Characteristics and Recurrence-Free Survival of Rare Variants of Papillary Thyroid Carcinomas in Korea: A Retrospective Study |
Page:619—627 |
| 15. Reference Values for Skeletal Muscle Mass at the Third Lumbar Vertebral Level Measured by Computed Tomography in a Healthy Korean Population |
Page:672—677 |
| 16. Insights from a Prospective Follow-up of Thyroid Function and Autoimmunity among COVID-19 Survivors |
Page:582—589 |
| 17. Association of Protein Z with Prediabetes and Type 2 Diabetes |
Page:637—646 |
| 18. Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients |
Page:599—606 |
| 19. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma |
Page:697—701 |
| 20. Asian Conference on Tumor Ablation Guidelines for Adrenal Tumor Ablation |
Page:553—563 |
| 21. Update on Glucocorticoid Induced Osteoporosis |
Page:536—543 |
| 22. Normocalcemic Primary Hyperparathyroidism: Need for a Standardized Clinical Approach |
Page:525—535 |
| 23. The Clinical Characteristics of Gestational Diabetes Mellitus in Korea: A National Health Information Database Study |
Page:628—636 |
| 24. Effect of Cigarette Smoking on Thyroid Cancer: Meta-Analysis |
Page:590—598 |
| 25. A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol |
Page:574—581 |
| 26. Descriptive Epidemiology and Survival Analysis of Prolactinomas and Cushing’s Disease in Korea |
Page:688—696 |
| 27. Identification of Protein Z as a Potential Novel Biomarker for the Diagnosis of Prediabetes |
Page:572—573 |
| 28. Receptor-Mediated Muscle Homeostasis as a Target for Sarcopenia Therapeutics |
Page:478—490 |
| 29. Expression of LONP1 Is High in Visceral Adipose Tissue in Obesity, and Is Associated with Glucose and Lipid Metabolism |
Page:661—671 |
| 30. Long-Term Treatment of Postmenopausal Osteoporosis |
Page:544—552 |
| 31. Current Guidelines for Management of Medullary Thyroid Carcinoma |
Page:514—524 |
| 32. Evaluation of Iodine Status among Korean Patients with Papillary Thyroid Cancer Using Dietary and Urinary Iodine |
Page:607—618 |
| 33. Efficacy and Safety of the New Appetite Suppressant, Liraglutide: A Meta-Analysis of Randomized Controlled Trials |
Page:647—660 |
| 34. Cushing Syndrome Associated Myopathy: It Is Time for a Change |
Page:564—571 |
| 35. Subclinical Hypothyroidism: Prevalence, Health Impact, and Treatment Landscape |
Page:500—513 |
| 36. Recent Advances in Understanding Peripheral Taste Decoding I: 2010 to 2020 |
Page:469—477 |
| 37. Antithyroid Drug Treatment in Graves’ Disease |
Page:491—499 |
| 38. Heart Rate Variability in Postoperative Patients with Nonfunctioning Pituitary Adenoma |
Page:678—687 |
| 39. Clinicopathological Characteristics and Recurrence-Free Survival of Rare Variants of Papillary Thyroid Carcinomas in Korea: A Retrospective Study |
Page:619—627 |
| 40. Reference Values for Skeletal Muscle Mass at the Third Lumbar Vertebral Level Measured by Computed Tomography in a Healthy Korean Population |
Page:672—677 |
| 41. Insights from a Prospective Follow-up of Thyroid Function and Autoimmunity among COVID-19 Survivors |
Page:582—589 |
| 42. Association of Protein Z with Prediabetes and Type 2 Diabetes |
Page:637—646 |
| 43. Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients |
Page:599—606 |
| 44. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma |
Page:697—701 |
| 45. Asian Conference on Tumor Ablation Guidelines for Adrenal Tumor Ablation |
Page:553—563 |
| 46. Update on Glucocorticoid Induced Osteoporosis |
Page:536—543 |
| 47. Normocalcemic Primary Hyperparathyroidism: Need for a Standardized Clinical Approach |
Page:525—535 |
| 48. The Clinical Characteristics of Gestational Diabetes Mellitus in Korea: A National Health Information Database Study |
Page:628—636 |
| 49. Effect of Cigarette Smoking on Thyroid Cancer: Meta-Analysis |
Page:590—598 |
| 50. A Multicenter, Randomized, Controlled Trial for Assessing the Usefulness of Suppressing Thyroid Stimulating Hormone Target Levels after Thyroid Lobectomy in Low to Intermediate Risk Thyroid Cancer Patients (MASTER): A Study Protocol |
Page:574—581 |
